Cabazitaxel (CBZ) activity in men with metastatic castration resistant prostate cancer (mCRPC) with and without DNA damage repair (DDR) defects
No Thumbnail Available
Identifiers
Date
2020-09-01
Authors
Aldea, M.
Lam, L.
Llacer Perez, C.
Saint-Ghislain, M.
Gravis Mescam, G.
Flechon, A.
Roubaud, G.
Barthelemy, P.
Ricci, F.
Priou, F.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Metrics
Export
